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Background: Deep sternal wound infection is a serious and potentially lethal
complication of cardiac surgery when performed through a median sternotomy. We
describe the outcome of a new treatment strategy with C-reactive protein level–
guided vacuum-assisted closure used at our department.
Methods: Data from 16 consecutive adult patients who had deep sternal wound
infections after cardiac surgery were reviewed. Patients with superficial infection or
sterile dehiscence were not included. All patients with postoperative deep sternal
wound infections were treated with first-line vacuum-assisted closure therapy,
followed by direct surgical closure. A purpose-built vacuum-assisted closure system
consisting of polyurethane foam pieces and a special pump unit was used. The foam
was placed in the wound after debridement of foreign material and necrotic tissue.
The wound was covered with adhesive drape and connected to the pump unit, which
was programmed to create a continuous negative pressure of 125 mm Hg in the
wound cavity. Intravenous antibiotics were given according to tissue-culture results.
The patients were immediately extubated after the operation. When ingrowth of
granulation tissue was observed in all parts of the wound and the plasma C-reactive
protein level showed a steady decline to 30 to 70 mg/L or less without confounding
factors, such as tissue injuries or concomitant infections, the sternotomy was
rewired, and the wound was closed.
Results: All patients were alive and free from deep sternal wound infection 3 months
after the operation. The median vacuum-assisted closure treatment time until sur-
gical closure was 9 days (range, 3-34 days), and the median C-reactive protein level
at closure was 45 mg/L (range, 20-173 mg/L). The median hospital stay was 22 days
(range, 12-120 days).
Conclusions: Early vacuum-assisted closure treatment, followed by surgical closure
guided by the plasma C-reactive protein level, is a reliable and easily applied new
strategy in patients with postoperative deep sternal wound infection.
Deep sternal wound infection is a serious complication of cardiacsurgery with both human and economic consequences.1,2 Thereported incidence varies from 1% to 5% of all sternotomyprocedures.3,4 Mortality has been reported to range between 0%and 35% in different studies.5-7 The established treatment at mostcenters involves surgical debridement, drainage, irrigation, and
delayed closure with reconstruction with omentum or a pectoral muscle flap.7,8
Despite numerous advances in different reconstructive surgical techniques, the
infected and frequently dehisced poststernotomy wound continues to be a treatment
challenge, and optimal management is still a matter of controversy. The overall aim
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is to find a safe, standardized, and less invasive method to
heal these wounds completely by first intention.
In this article we present a new method for postoperative
deep sternal wound infection: a combination of vacuum-
assisted closure with secondary surgical closure of the ster-
notomy at a time point guided by daily measurements of the
systemic plasma concentration of C-reactive protein. The
vacuum-assisted closure treatment will increase the elimi-
nation rate of bacteria present in the wound,9 and this might
decrease the amount of inflammatory cytokines released,
which, as a result, will affect the initiation of the acute-
phase reaction with a concomitant decline in systemic
plasma C-reactive protein levels. With this new strategy,
several aspects of infected wound treatment are combined:
objective monitoring, removal of all foreign material, ade-
quate drainage, accelerated granulation, complete coverage,
and obliteration of the wound cavity.
Methods
The most common signs leading to diagnosis were an unstable
sternum with secretion, fever, leukocytosis, and high plasma C-
reactive protein levels. Debridement of clearly necrotic and in-
fected bone tissue was performed at the time of the vacuum-
assisted closure application. This was carried out in a conservative
and bone-saving manner. At the same time, 5 mediastinal tissue
cultures were obtained from the wound (Table 1). Antibiotic
treatment was started with intravenous vancomycin in all patients.
The doses were adjusted according to the renal status of the
patients. This treatment continued until the tissue cultures arrived.
The regimen was changed according to sensitivity (Table 1). No
vancomycin-resistant bacteria were found. The intravenous ther-
apy continued for 7 days after sternal closure. The oral regimen
continued for 4 weeks as a combined therapy, according to the
sensitivity of the strains.
A sterile polyurethane foam dressing with an open-pore struc-
ture of 400 to 600 m (KCI, Copenhagen, Denmark) was trimmed
to fit in the wound. The first layer was placed substernally. A
second and third layer of polyurethane foam dressing were placed
between the sternal edges and the subcutaneous layer, respectively.
The open wound was sealed with transparent adhesive drape,
which overlapped the wound by 8 to 10 cm. A noncollapsible
evacuation tube connected the controlled closed wound to a pur-
pose-built vacuum source. We used a VAC pump unit (KCI),
which delivers a continuous or intermittent negative pressure of 25
to 200 mm Hg. A continuous negative pressure of 125 mm Hg was
used in all cases. A canister in the pump unit collects the exudate
from the wound.
The polyurethane foam dressing was changed twice a week
under aseptic conditions. This was done after achievement of full
anesthesia. At the time of dressing change, avascular and necrotic
bone tissue was demarked with the vacuum-assisted closure ther-
apy by lack of granulation tissue and can easily be removed. Most
of the patients were extubated immediately after vacuum-assisted
closure application and could leave the intensive care unit after 2
to 3 hours. When visual inspection showed the wound to be well
vascularized and covered with granulation tissue and the C-reac-
tive protein level had declined to 30 to 70 mg/L without confound-
ing factors, such as the presence of tissue injuries or infection
elsewhere, the wound was considered to be free from infection.
The sternotomy was rewired without further debridement with
interrupted steel wire (Stahldraht; Johnson and Johnsson, Brussels,
Belgium), and the skin was closed with interrupted stitches (Der-
malon 2–0; Davis and Geck, St Louis, Mo).
Results
Between February 1999 and December 2000, 16 consecu-
tive patients with postoperative deep sternal wound infec-
tion after cardiac surgery were identified and treated with
first-line vacuum-assisted closure therapy. During this time
interval, a total of 2201 patients were operated on through a
median sternotomy in our institution, giving an incidence of
deep sternal wound infection of approximately 0.7%. Thir-
teen (81%) patients were men, and 3 (19%) were women.
The median age of the male patients was 68 years (range,
49-82 years), and that for the female patients was 67 years
(range, 63-73 years).
The median time between the initial cardiac operation
and the diagnosis of deep sternal wound infection was 16
days (range, 3-52 days). The median duration of vacuum-
assisted closure treatment was 9 days (range, 4-34 days),
and the median hospital stay was 22 days (range, 12-120
days). Nine of the 16 patients were able to leave the inten-
sive care unit after 2 to 3 hours of observation (Table 1).
The median systemic plasma C-reactive protein level
showed a progressive decline during treatment and was 45
mg/L (range, 20-173 mg/L) at surgical closure of the ster-
notomy (Figure 1, A).
All patients were alive and free from sternal infection 3
months after secondary closure. In 2 patients further surgi-
cal intervention was necessary because of fistulas after
rewiring. These 2 patients had otherwise stable and healed
sternotomies.
Discussion
Sealed negative-pressure treatment was first described in the
early 1990s as a method to accelerate wound healing in
patients with open fractures10 and resulted in the develop-
ment of a vacuum-assisted closure system.11,12 Negative-
pressure treatment of wounds has been used with success in
reconstructive and trauma surgery.13,14 A particular benefit
of applying vacuum into the wound is to promote healing in
complicated cases in which established treatment fails.15
Tang and coworkers16 successfully treated 15 patients with
sternotomy wound infections with vacuum-assisted closure
for 22 to 69 days without surgical closure. We consider this
a safe method, and the risk of reinfection is low. It was time
consuming, and the sternum was not rewired, but this strat-
egy would still be an option in patients who are otherwise
obsolete surgical candidates.
Because of our former experience with patients in whom
deep sternal wound infection has been treated with major
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reconstructive surgery, which causes extensive hospitaliza-
tion and patient morbidity, we developed a new strategy
using vacuum-assisted closure for patients with deep sternal
wound infection. Serial measurements of systemic C-reac-
tive protein were performed during vacuum-assisted closure
and revealed a typical pattern (Figure 1, A). We used this to
guide us during the treatment, and closure of the sternum
was performed when the plasma levels were progressively
declining to 30 to 70 mg/L. At this level, the wound was
considered ready for closure. After secondary closure, the
C-reactive protein level again rose and reached a peak
within 72 hours before declining to preclosure levels. This
elevation corresponded to the surgical trauma17 and was not
a sign of reinfection.
The white blood cell count was helpful for the diagnosis
of deep sternal wound infection but did not show a trend
Figure 1. A, Median C-reactive protein levels are presented in a box plot 6 days before and 6 days after sternal
closure. The whiskers represent the range of the data, the boxes express the upper and lower quartiles, and the
central line shows the median. Diamonds, Outliers. B, Median white blood cell count levels are presented in a box
plot 6 days before and 6 days after sternal closure. The whiskers represent the range of the data, the boxes express
the upper and lower quartiles, and the central line shows the median. Diamonds, Outliers.
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useful for guide lining of sternal closure and monitoring of
the vacuum-assisted closure therapy (Figure 1, B). We
therefore suggest the monitoring of plasma C-reactive pro-
tein (Figure 1, A) to be an adjunct for wound control18,19 and
for assessing the appropriate time for sternal closure during
high negative-pressure therapy.
In 3 patients (patients 2, 8, and 15) the sternotomy was
rewired despite a markedly persistent elevation in their
C-reactive protein values (Figure 2). In these patients the
sternal wound was not the source of infection. Two patients
(patients 2 and 8) were treated for 32 and 34 days, respec-
tively. Patient 2 had a stroke, multiorgan failure, and bilat-
eral pneumonia. Patient 8 had peritonitis and was treated for
bowel obstruction caused by chronic peritoneal dialysis. In
these 2 patients the C-reactive protein level remained high
because of concomitant infection, and they stayed in the
hospital for other reasons than sternal infection. Patient 15
had massive pectoral muscle necrosis caused by cardiac
resuscitation, followed by an emergency valve operation.
The sternum was rewired, and the muscle necrosis was
partially resected and separately drained. These 3 patients
were moribund as the vacuum-assisted closure therapy was
initiated. They recovered but required longer hospitalization
because of the complexity of their diseases (Table 1). In
cases in which the C-reactive protein level remains high as
a result of confounding factors, sternal tissue cultures are
required to decide when to close the sternotomy.
The duration of vacuum-assisted closure treatment until
sternal closure in a typical patient without other concomi-
tant infection was approximately 7 days (Table 1). During
this time, the patient was mobilized in the ward, had no
Figure 3. Day 1 after sternal revision and vacuum-assisted closure
application. The patient is mobilized in the ward.
Figure 2. Individual C-reactive protein level at the time of sternal wound closure.
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pain, and had practically no need for nursing requirements
regarding the wound (Figure 3).
Furthermore, when the vacuum-assisted closure treat-
ment is activated with a negative pressure of 125 mm Hg,
the foam will become firm and act as a splint in the sternum.
This enables early mobilization and supports full lung func-
tion with no more pain than after a rewired sternotomy.
Surgical closure can be carried out when the patient has
returned to an anabolic phase without infection and with a
profuse bed of fresh granulation tissue in the wound. In
addition, our strategy does not require transposition of
omentum or muscle flaps.
Most of the patients had positive cultures with vanco-
mycin- or clindamycin-sensitive coagulase-negative staph-
ylococci (Table 1), which is a growing problem among
postoperative cardiac patients.2,20 Therefore another advan-
tage of this closed and controlled system is a decreased risk
of contamination to the environment.
Hemodynamic instability, bleeding tendency, arrhyth-
mia, and chest pain were considered potential problems.
However, none of our patients experienced any of these.
Some air leakage was noticed but could easily be handled
with additional adhesive drape.
Animal studies by Morykwas and coworkers9 showed that
vacuum-assisted closure accelerated the elimination of edema
and bacteria in the wound. Additionally, an increase in blood
flow by 3 to 4 times and an accelerated ingrowth of granulation
tissue by 2 to 3 times was noted. All these features will
increase the wound vascularity, which is of utmost importance
for early secondary closure and optimal wound healing in a
patient with deep sternal wound infection.
The results presented in this article describe a new strategy
for treatment of deep sternal wound infection, with possible
positive effects on morbidity and cost-effectiveness. More
studies are needed for proper comparison with the standard
treatment of early sternectomy and muscle flap closure.
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1 67 F CABG CoNS Vanco 16 7 6 19
2 66 M P-Homograft CoNS Cipro 17 32 32 84
3 80 M CABG  AVR CoNS Vanco  Imi 52 4 0 17
4 82 M CABG E cloace Vanco  Cipro 8 6 0 13
5 63 M CABG CoNS Vanco 20 6 0 17
6 69 M CABG CoNS Vanco  Cipro 13 18 21 28
7 57 M CABG CoNS Vanco 14 9 0 25
8 55 M CABG CoNS Vanco 17 34 34 120
9 73 F CABG  Alfieri CoNS Vanco 15 5 0 25
10 49 M Ross CoNS Vanco 14 3 0 12
11 68 M CABG S aureus Clinda 13 13 0 19
12 79 M CABG CoNS Vanco  Cipro 7 12 0 31
13 77 M AVR CoNS Vanco 23 8 3 15
14 71 M CABG CoNS  E coli Vanco 18 9 8 49
15 57 M CABG  AVR CoNS  E coli Vanco  Imi 3 9 24 87
16 63 F CABG CoNS Vanco 22 10 0 17
Presentation, postoperative day, Days from initial cardiac operation to diagnosis of sternal infection; VAC (d), days with vacuum-assisted closure therapy
before sternal rewiring; ICU (d), length of stay in the intensive care unit; CABG, coronary artery bypass grafting; P-Homograft, pulmonary homograft
replacement; AVR, aortic valve replacement; Alfieri, mitral valve plasty ad modum Alfieri; Ross, pulmonary autograft; CoNS, coagulase-negative
staphylococcus; E. cloace, Enterobactus cloace; E. coli, Escherichia coli; S. aureus, Staphylococcus aureus; Vanco, vancomycin; Cipro, ciprofloxacin; Imi,
imipenem; Clinda, clindamycin.
Gustafsson et al Surgery for Acquired Cardiovascular Disease
The Journal of Thoracic and Cardiovascular Surgery ● Volume 123, Number 5 899
A
CD
8. Jones G, Jurkiewicz MJ, Bostwick J, Wood R, Bried JT, Culbertson J,
et al. Management of the infected median sternotomy wound with
muscle flaps. The Emory 20-year experience. Ann Surg. 1997;225:
766-76.
9. Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W. Vac-
uum-assisted closure: a new method for wound control and treat-
ment: animal studies and basic foundation. Ann Plast Surg. 1997;
38:553-62.
10. Fleischmann W, Strecker W, Bombelli M, Kinzl L. Vacuum sealing as
treatment of soft tissue damage in open fractures. Unfallchirurg.
1993;96:488-92.
11. Argenta LC, Morykwas MJ. Vacuum-assisted closure: a new method
for wound control and treatment: clinical experience. Ann Plast Surg.
1997;38:563-76.
12. Voinchet V, Magalon G. Vacuum assisted closure. Wound healing by
negative pressure. Ann Chir Plast Esthet. 1996;41:583-9.
13. Greer SE, Longaker MT, Margiotta M, Mathews AJ, Kasabian A. The
use of subatmospheric pressure dressing for the coverage of radial
forearm free flap donor-site exposed tendon complications. Ann Plast
Surg. 1999;43:551-4.
14. Barker DE, Kaufman HJ, Smith LA, Ciraulo DL, Richart CL, Burns
RP. Vacuum pack technique of temporary abdominal closure: a 7-year
experience with 112 patients. J Trauma. 2000;48:201-6.
15. Blackburn JH, Boemi L, Hall WW, Jeffords K, Hauck RM, Banducci
DR, et al. Negative-pressure dressings as a bolster for skin grafts. Ann
Plast Surg. 1998;40:453-7.
16. Tang AT, Ohri SK, Haw MP. Novel application of vacuum assisted
closure technique to the treatment of sternotomy wound infection. Eur
J Cardiothorac Surg. 2000;17:482-4.
17. Pritchett JW. C-reactive protein levels determine the severity of soft-
tissue injuries. Am J Orthop. 1996;25:759-61.
18. Icard P, Fleury JP, Regnard JF, Libert JM, Magdeleinat P, Gharbi
N, et al. Utility of C-reactive protein measurements for empyema
diagnosis after pneumonectomy. Ann Thorac Surg. 1994;57:933-6.
19. Du Clos TW. Function of C-reactive protein. Ann Med. 2000;32:
274-8.
20. Tegnell A, Aren C, Ohman L. Coagulase-negative staphylococci and
sternal infections after cardiac operation. Ann Thorac Surg. 2000;69:
1104-9.
Surgery for Acquired Cardiovascular Disease Gustafsson et al
900 The Journal of Thoracic and Cardiovascular Surgery ● May 2002
A
CD
